CPhI Worldwide announced the launch of the CPhI Pharma InsightsUSA market report, a joint venture with InformEx, which will provide European perspectives on the accessibility, growth, and export market in the United States. The report is designed to encourage and increase trade harmonization between the two major pharma economies of the world, the sponsors say.
The US country report, which will be distributed in July 2014, follows the launch of the CPhI annual report (released at CPhI Worldwide, Frankfurt, October 2013). The new report, which analyzes current and future trends across the US pharma landscape, will feature expert opinion from Europe’s leading companies, contrasted with US internal perceptions to provide a holistic view of the major trade flows within the region, according to report sponsors.
The report will examine the areas in which European companies are looking to work with US counterparts, import into the US and, domestic and export manufacturing across pharma’s fine, specialty, and custom chemicals market.
Following last year’s report, which covered the global industry, CPhI will now examine trends within specific leading pharma economies.